Show simple item record

dc.contributor.authorBirungi, Mariam
dc.contributor.authorNakibuuka, Jane
dc.contributor.authorKaddumukasa, Mark
dc.contributor.authorNajjuma, Josephine
dc.contributor.authorBurant, Christopher J.
dc.contributor.authorMoore, Shirley
dc.contributor.authorBlixen, Carol
dc.contributor.authorKatabira, Elly T.
dc.contributor.authorSajatovic, Martha
dc.contributor.authorMbalinda, Scovia Nalugo
dc.date.accessioned2024-11-18T14:21:18Z
dc.date.available2024-11-18T14:21:18Z
dc.date.issued2024
dc.identifier.citationBirungi, M., Nakibuuka, J., Kaddumukasa, M., Najjuma, J., Burant, C. J., Moore, S., ... & Mbalinda, S. N. (2024). Administration patterns of magnesium sulphate for women with preeclampsia and immediate newborn outcomes in Kawempe National Referral Hospital-Uganda: a cohort study. BMC Pregnancy and Childbirth, 24, 753.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/3937
dc.description.abstractBackground: Preeclampsia is the second leading cause of maternal death in Uganda. WHO recommends using magnesium sulphate (MgSO4) to prevent and treat preeclampsia with severe features (PEC) and eclampsia. MgSO4 is used to prevent eclampsia and treat women who experience an eclamptic convulsion to avoid severe maternal/ infant illnesses and death. We set out to assess MgSO4 administration patterns in women with PEC or eclampsia and the immediate newborn outcomes of neonates. Methods: This was an analytical observational cohort study at Kawempe National Referral Hospital in Uganda. Two hundred ten pregnant mothers with PEC or eclampsia were recruited in the study after receiving the loading dose of MgSO4 and then followed through labour and delivery to observe MgSO4 administration patterns and immediate newborn out comes using Apgar and Thompson scores. SPSS version 23 was used to analyse data, and both bivariate and multivariate logistic regressions were used to determine factors associated with the low Apgar score at five minutes. Results: Overall, majority of the patients received more than one dose with 33.3% received a sixth dose of MgSO4. The majority, 84.8%, of the mothers delivered live babies, 31.0% babies had complications, and were admitted to the neonatal intensive care unit (NICU). NICU admissions were mostly due to respiratory distress21.4%, preterm delivery21.0%, and 5.5% died within seven days. Majority 93.3% of the newborns had an Apgar score of seven and above at five minutes, of the newborns who were Thompson scored, 70.4% scored between 1 to 10 which is mild HIE. Initiation of MgSO4 treatment within one hour from prescription (AOR = 0.49, CI: 0.01–1.94), 4-hourly timing of the first maintenance dose (AOR = 0.22, CI: 0.06–0.79) and having complete doses of MgSO4 treatment (AOR = 0.89, CI: 0.03–3.05) decreased the likelihood of having low Apgar scores at five minutes. Conclusions: Timely administration of the first maintenance dose of MgSO4 decreases the likelihood of low Apgar score at 5 min and NICU admission in newborns, and most NICU admissions were due to respiratory distress and pre term delivery.en_US
dc.description.sponsorshipNational Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS118544.en_US
dc.language.isoen_USen_US
dc.publisherBMC Pregnancy and Childbirthen_US
dc.subjectPreeclampsiaen_US
dc.subjectIntrapartumen_US
dc.subjectMagnesium sulphateen_US
dc.subjectNewborn outcomesen_US
dc.subjectApgar scoreen_US
dc.subjectUgandaen_US
dc.titleAdministration patterns of magnesium sulphate for women with preeclampsia and immediate newborn outcomes in Kawempe National Referral Hospital-Uganda: a cohort studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record